We found no correlation between anti–spike saliva IgA and serum anti–nucleocapsid IgG levels (eFigure 2 in Supplement 1) that could have pointed in the direction of asymptomatic infections to explain a late increase in anti–spike saliva IgA levels in the mRNA-1273 vaccine group. The gene discussed is CD79A; the disease is infection.